Company Profile

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE1645.00-28.5 (-1.7 % )
PREV CLOSE (Rs.) 1673.50
OPEN PRICE (Rs.) 1679.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4267
TODAY'S LOW / HIGH (Rs.)1636.95 1710.55
52 WK LOW / HIGH (Rs.)892.6 1984.75
NSE1662.90 -7.5 (-0.45 % )
PREV CLOSE(Rs.) 1670.40
OPEN PRICE (Rs.) 1685.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1662.90 (430 )
VOLUME 51424
TODAY'S LOW / HIGH(Rs.) 1641.10 1711.90
52 WK LOW / HIGH (Rs.)883.3 1985

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.00
TTM EPS (Rs.) 57.00
P/E Ratio 28.86
Book Value (Rs.) 248.67
Face Value (Rs.) 2
MCap (Rs. in Mn) 127129.05
Price/Earning (TTM) 25.01
Price/Sales (TTM) 6.52
Price/Book (MRQ) 6.62
PAT Margin (%) 23.63
ROCE (%) 36.33
Incorporation Year : 1976

Management Info :

Ranjit Shahani - Chairman - Managing Director

Registered Office :

Address : Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, Worli,
Mumbai,
Maharashtra-400030

Phone : 022- 2482 2222/2493 0918

Website : www.jbcpl.com

Registrar's Details : Datamatics Business Solutions Ltd.
(Formerly Datamatics Financial Services Ltd) , Plot No A / 16 & A / 17,MIDC, Part B,Cross Lane, Marol , Andheri (E),Mumbai
Listing : BSE, NSE, MCX
NEWS More
04Oct10-04-2021$JB Chemicals & Pharmaceuticals informs about revised contact details of KMPs JB Chemicals & Pharmaceutica

In furtherance to letter dated July 29, 2021, JB Chemicals & Pharmaceuticals has informed about the revised contact details of the Key Managerial Personnel (KMPs) authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to Stock Exchanges, as enclosed.

The above information is a part of company’s filings submitted to BSE.

In furtherance to letter dated July 29, 2021, JB Chemicals &..
17Sep09-17-2021$J.B. Chemicals & Pharmaceuticals informs about disclosure J.B. Chemicals & Pharmaceuti

J.B. Chemicals & Pharmaceuticals has informed about submission of application to the Stock Exchanges for re-classification of status from promoter/promoter group to public pursuant to Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

The above information is a part of company’s filings submitted to BSE.

J.B. Chemicals & Pharmaceuticals has informed about submiss..
11Aug08-11-2021$J.B. Chemicals & Pharmaceuticals informs about AGM notice J.B. Chemicals & Pharmaceuti

In compliance with the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, J.B. Chemicals & Pharmaceuticals has informed that it enclosed the notice of the Annual General Meeting of the Company to be held on September 9, 2021 at 3.30 pm (IST) through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).

The above information is a part of company’s filings submitted to BSE.

In compliance with the Regulation 30 of SEBI (Listing Obligatio..
11Aug08-11-2021$J.B. Chemicals & Pharmaceuticals informs about record date J.B. Chemicals & Pharmaceuti

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, J.B. Chemicals & Pharmaceuticals has informed that the Company has fixed September 2, 2021 as record date, to ascertain eligibility of the of the beneficial owners/ holders of the Company's shares to receive the final dividend for FY2020-2021.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 42 of the SEBI (Listing Obligations and..
11Aug08-11-2021$ Grant Of Options Under Employee Stock Option Scheme Grant Of Options Under Empl
Grant of Options under Employee Stock Option Scheme -Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015 read with read with the Securities and Exchange Board of India circular bearing reference no. CIR/CFD/CMD/4/2015 dated September 9, 2015
Grant of Options under Employee Stock Option Scheme -Disclosure..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit1153.124470.84
Gross Profit 1528.22 5937.07
Operating Profit 1711.866682.54
Net Sales 5463.0118919.96
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
SMS Lifesciences (BSE)
 998.75 (14.90%)
M.Cap ( in Cr)
301.95
Gland Pharma (BSE)
 3596.90 (2.06%)
M.Cap ( in Cr)
59097.74
Kwality Pharma (BSE)
 1057.45 (5.00%)
M.Cap ( in Cr)
1097.23
Ajanta Pharma (BSE)
 2131.00 (2.04%)
M.Cap ( in Cr)
18440.77
Suven Pharma (BSE)
 544.90 (6.89%)
M.Cap ( in Cr)
13871.24
Shareholding Pattern More
PROMOTERS 55.91 %
NON-INSTITUTION 20.12 %
MUTUAL FUNDS/UTI 12.8 %
FI/BANKS/INSURANCE 1.96 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes